PV pharm branch, vendor, cage 0U9U0
Ended Awarded Last action
- Contract number
- SPE2D826F13NF
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $111,228
Award facts
- Contract value 100% obligated
- $111,228.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
Amerisourcebergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $111,228.00 by the Defense Logistics Agency's Medical Supply Chain on January 13, 2026, with a completion date of January 14, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (designated SPE2DX), which is valued at $999,999,999.00 through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling Amerisourcebergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and medical devices to support military healthcare programs worldwide.
Amerisourcebergen Drug Corp operates as a subsidiary of parent company Cencora, Inc., which also conducts business under the Amerisourcebergen name. Through its federal contract portfolio, the company supplies critical pharmaceutical commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The delivery order aligns with the Defense Logistics Agency's broader Pharmaceutical Prime Vendor Global Program, which is planning to establish Generation V contracts with multiple awards across separate regions, positioning Amerisourcebergen Drug Corp as a key strategic supplier for federal military and veteran healthcare logistics.
Quick answers
Who was awarded contract SPE2D826F13NF?
SPE2D826F13NF was awarded to Amerisourcebergen Drug Corp by Medical Supply Chain (Troop Support) on January 13, 2026.
How much is contract SPE2D826F13NF worth?
The government has obligated $111,228 on SPE2D826F13NF.
Is contract SPE2D826F13NF an order under another contract?
Yes. SPE2D826F13NF is a delivery order under SPE2DX22D0029, an indefinite delivery contract.
Was contract SPE2D826F13NF competed?
The extent of competition for SPE2D826F13NF was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award